{"id":"https://openalex.org/W2013457279","doi":"https://doi.org/10.1111/j.1600-0447.2007.01130.x","title":"Augmentation of antidepressants with atypical antipsychotics for treatment\u2010resistant major depressive disorder","display_name":"Augmentation of antidepressants with atypical antipsychotics for treatment\u2010resistant major depressive disorder","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-08","ids":{"openalex":"https://openalex.org/W2013457279","doi":"https://doi.org/10.1111/j.1600-0447.2007.01130.x","mag":"2013457279","pmid":"https://pubmed.ncbi.nlm.nih.gov/18190674"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0447.2007.01130.x","doi":"https://doi.org/10.1111/j.1600-0447.2007.01130.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.2007.01130.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2013457279"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010294016","display_name":"Richard Charles Shelton","orcid":"https://orcid.org/0000-0002-3806-4208","observed_orcids":["https://orcid.org/0000-0002-3806-4208"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Richard C. Shelton","raw_affiliation_strings":["Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA. richard.shelton@vanderbilt.edu","Department of Psychiatry, Vanderbilt University School of Medicine, Nashville TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA. richard.shelton@vanderbilt.edu","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Department of Psychiatry, Vanderbilt University School of Medicine, Nashville TN, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045819737","display_name":"George I. Papakostas","orcid":"https://orcid.org/0000-0002-8886-1416","observed_orcids":["https://orcid.org/0000-0002-8886-1416"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George I. Papakostas","raw_affiliation_strings":["Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5010294016"],"corresponding_institution_ids":["https://openalex.org/I200719446"],"apc_list":{"value":4880,"currency":"USD","value_usd":4880},"apc_paid":null,"fwci":1.479,"has_fulltext":false,"cited_by_count":127,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.85458167,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"117","issue":"4","first_page":"253","last_page":"259"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9539999961853027},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.8740000128746033},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9890000224113464},{"id":"https://openalex.org/keywords/antidepressant-augmentation","display_name":"antidepressant augmentation","score":0.8899999856948853},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.7559999823570251},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.9559999704360962},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.6383855938911438},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.6267001628875732},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4543232023715973},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.4536322057247162},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3892304599285126},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3386555314064026},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0741177499294281}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014196","descriptor_name":"Trazodone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014196","descriptor_name":"Trazodone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D058830","descriptor_name":"Serotonin 5-HT2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065127","descriptor_name":"Dopamine D2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0447.2007.01130.x","doi":"https://doi.org/10.1111/j.1600-0447.2007.01130.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.2007.01130.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},{"id":"pmid:18190674","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18190674","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta psychiatrica Scandinavica","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4994101276","display_name":"MOLECULAR NEUROBIOLOGY OF DEPRESSION","funder_award_id":"K24MH001741","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G6574695799","display_name":"S-Adenosyl Methionine(SAMe)Augmentation of SSRIs in MDD","funder_award_id":"K23MH069629","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W121491609","https://openalex.org/W1654634226","https://openalex.org/W1781768774","https://openalex.org/W1964176367","https://openalex.org/W1970133878","https://openalex.org/W1972245284","https://openalex.org/W1972676417","https://openalex.org/W1973799461","https://openalex.org/W1978250749","https://openalex.org/W1981445835","https://openalex.org/W1983900457","https://openalex.org/W1985205937","https://openalex.org/W1985517071","https://openalex.org/W1988730265","https://openalex.org/W2003033559","https://openalex.org/W2005066505","https://openalex.org/W2006050379","https://openalex.org/W2030193619","https://openalex.org/W2032149427","https://openalex.org/W2032902988","https://openalex.org/W2034750014","https://openalex.org/W2037486662","https://openalex.org/W2046695234","https://openalex.org/W2064002445","https://openalex.org/W2067495470","https://openalex.org/W2068927187","https://openalex.org/W2075901584","https://openalex.org/W2083499348","https://openalex.org/W2091451566","https://openalex.org/W2092430566","https://openalex.org/W2095109387","https://openalex.org/W2095213614","https://openalex.org/W2104516271","https://openalex.org/W2110341150","https://openalex.org/W2114613490","https://openalex.org/W2114693958","https://openalex.org/W2125094332","https://openalex.org/W2126893363","https://openalex.org/W2131083220","https://openalex.org/W2132324173","https://openalex.org/W2149402043","https://openalex.org/W2153381163","https://openalex.org/W2156971648","https://openalex.org/W2160070901","https://openalex.org/W2170332928","https://openalex.org/W2410264357","https://openalex.org/W2411226917","https://openalex.org/W6636866193"],"related_works":["https://openalex.org/W2399508871","https://openalex.org/W1970677460","https://openalex.org/W3097343353","https://openalex.org/W2029066588","https://openalex.org/W2376748726","https://openalex.org/W2011467143","https://openalex.org/W2064070148","https://openalex.org/W2071402607","https://openalex.org/W2160912455","https://openalex.org/W1965831048"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Atypical":[1],"antipsychotics":[2],"(AAPs)":[3],"have":[4,87,100],"been":[5],"hypothesized":[6],"to":[7,70],"be":[8,145],"beneficial":[9,128],"in":[10,31,102,136,147],"treatment-resistant":[11],"depression":[12],"(TRD).":[13],"This":[14],"paper":[15],"will":[16,22],"review":[17],"a":[18],"biochemical":[19],"rationale":[20],"and":[21,42,64,116],"summarize":[23],"the":[24,27,43,48,54,72,89,127],"data":[25],"regarding":[26,110],"effectiveness":[28,73,90],"of":[29,39,53,74,91,95,130],"AAPs":[30,75,99,131],"TRD.":[32,80,137],"METHOD:":[33],"Studies":[34],"were":[35],"identified":[36],"using":[37],"searches":[38],"Pubmed/Medline,":[40],"EMBase":[41],"Cochrane":[44],"databases":[45],"by":[46],"cross-referencing":[47],"term":[49],"'depression'":[50],"with":[51,77,134],"each":[52],"six":[55],"AAPs.":[56],"RESULTS:":[57],"After":[58],"initial":[59],"positive,":[60],"short":[61],"case":[62],"reports":[63],"clinical":[65,85],"trials,":[66],"larger":[67,83],"studies":[68],"failed":[69],"show":[71],"combined":[76,133],"antidepressants":[78],"for":[79,104,126],"More":[81],"recently,":[82],"scale":[84],"trials":[86],"supported":[88],"at":[92],"least":[93],"some":[94,124],"these":[96],"medications.":[97],"While":[98],"gained":[101],"popularity":[103],"TRD,":[105],"there":[106],"are":[107],"nagging":[108],"concerns":[109],"risks":[111,142],"such":[112],"as":[113],"metabolic":[114],"syndrome":[115],"tardive":[117],"dyskinesia.":[118],"CONCLUSION:":[119],"The":[120],"existing":[121],"research":[122],"provides":[123],"support":[125],"effects":[129],"when":[132],"SSRI's":[135],"These":[138],"medications":[139],"pose":[140],"significant":[141],"that":[143],"must":[144],"considered":[146],"their":[148],"use.":[149]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2013457279","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
